Oxytrol for Women (oxybutynin) Transdermal System

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   March 2016 DRUG FACTS LABEL The warnings section is now to read: “Sleepiness, dizziness, confusion, and blurry vision...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts